Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences World Biobanking Summit

Heiko Zimmermann's Biography



Heiko Zimmermann, Director/Professor, Fraunhofer Institute of Biomedical Engineering

Education and Scientific Carreer
1981-1991 Johannes-Brahms Gymnasium in Pinneberg, Germany
Callisburg Highschool, Texas, USA
1991-1998 Medical School; University Medical Center Hamburg, Germany
Duke University Medical School in Durham, North Carolina, USA
Harvard Medical School in Boston, Massachusetts, USA
Groote Schuur Hospital, University of Cape Town, South-Africa
1994 United States Medical Licensing Examination (USMLE) step 1
1998 United States Medical Licensing Examination (USMLE) step 2
1998 – 2001 Postgraduate course “Molecular Biology”, University Hamburg
1995 – 2000 Experimental thesis in Pharmacology University Medical Center Hamburg
1999 – 2001 Resident (Clinical Pharmacology), University Erlangen-Nuremberg
2001 – 2002 Resident & Lecturer (Clinical Pharmacology), University Erlangen-Nuremberg
2002 – 2004 Lecturer & Staff Scientist (Pharmacology), University of Hamburg
2004 – 2008 Assistant professor (Juniorprofessor; Pharmacology), University Hamburg
2006 Board certification in Pharmacology and Toxicology
2007 Habilitation and Venia Legendi for Pharmacology and Toxicology
2008 Chair position (W3) “Cardiac Pathobiology”, Justus-Liebig-University Giessen
(declined)
since 2008 Professor & Director, Department of Pharmacology (W3), Heart Research
Center Goettingen, Georg-August University Goettingen

Heiko Zimmermann Image

The Fraunhofer Technology Platform: Sustainable Integrated Biobanking for Biomedical Applications

Friday, 1 July 2011 at 16:30

Add to Calendar ▼2011-07-01 16:30:002011-07-01 17:30:00Europe/LondonThe Fraunhofer Technology Platform: Sustainable Integrated Biobanking for Biomedical ApplicationsSELECTBIOenquiries@selectbiosciences.com

The Fraunhofer Society Germany has developed through its institute IBMT together with industrial partners a fully integrated biobank platform comprising cryobiological, IT, and storage solutions for high quality cryo-biobanking at temperatures below -150°C. The presentation will describe the components of the platform as well as the use case of the HIV Specimen Cryorepository of the Bill & Melinda Gates Foundation.


Add to Calendar ▼2011-06-30 00:00:002011-07-01 00:00:00Europe/LondonWorld Biobanking SummitSELECTBIOenquiries@selectbiosciences.com